{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:11:24Z","timestamp":1790727084158,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Department of Health & Human Services | U.S. Public Health Service","doi-asserted-by":"publisher","award":["R01 CA190105"],"award-info":[{"award-number":["R01 CA190105"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Department of Health & Human Services | U.S. Public Health Service","doi-asserted-by":"publisher","award":["U01 CA143062"],"award-info":[{"award-number":["U01 CA143062"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | U.S. Public Health Service"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,7,20]]},"DOI":"10.1038\/s41416-021-01375-0","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T04:19:50Z","timestamp":1617769190000},"page":"229-239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors"],"prefix":"10.1038","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-8666","authenticated-orcid":false,"given":"Wei","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Katsoulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7511-2603","authenticated-orcid":false,"given":"Christopher J.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-3216","authenticated-orcid":false,"given":"Matthew B.","family":"Schabath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8888-7747","authenticated-orcid":false,"given":"Robert J.","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"1375_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon, K., Arends, J. & Baracos, V. Understanding the mechanisms and treatment options in cancer cachexia. Nat. Rev. Clin. Oncol. 10, 90\u201399 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1375_CR2","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00520-017-4022-z","volume":"26","author":"OM Vagnildhaug","year":"2018","unstructured":"Vagnildhaug, O. M., Balstad, T. R., Almberg, S. S., Brunelli, C., Knudsen, A. K., Kaasa, S. et al. A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer. Support Care Cancer 26, 1871\u20131880 (2018).","journal-title":"Support Care Cancer"},{"key":"1375_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrc927","volume":"2","author":"MJ Tisdale","year":"2002","unstructured":"Tisdale, M. J. Cachexia in cancer patients. Nat. Rev. Cancer 2, 862\u2013871 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"1375_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12, 489\u2013495 (2011).","journal-title":"Lancet Oncol."},{"key":"1375_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejca.2005.07.026","volume":"42","author":"M Muscaritoli","year":"2006","unstructured":"Muscaritoli, M., Bossola, M., Aversa, Z., Bellantone, R. & Fanelli, F. R. Prevention and treatment of cancer cachexia: new insights into an old problem. Eur. J. Cancer 42, 31\u201341 (2006).","journal-title":"Eur. J. Cancer"},{"key":"1375_CR6","first-page":"1","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C. & Fearon, K. C. Cancer-associated cachexia. Nat. Rev. Dis. Prim. 4, 1\u201318 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1375_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1183\/09031936.00144208","volume":"34","author":"RP Young","year":"2009","unstructured":"Young, R. P., Hopkins, R. J., Christmas, T., Black, P. N., Metcalf, P. & Gamble, G. D. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur. Respir. J. 34, 380\u2013386 (2009).","journal-title":"Eur. Respir. J."},{"key":"1375_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1183\/09031936.00074807","volume":"31","author":"P Wagner","year":"2008","unstructured":"Wagner, P. Possible mechanisms underlying the development of cachexia in COPD. Eur. Respir. J. 31, 492\u2013501 (2008).","journal-title":"Eur. Respir. J."},{"issue":"5_suppl","key":"1375_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/JCO.2020.38.5_suppl.44","volume":"38","author":"H Jo","year":"2020","unstructured":"Jo, H., Horinouchi, H., Yagishita, S., Shinno, Y., Okuma, Y., Yoshida, T. et al. Impact of cachexia in advanced NSCLC patients treated with PD-1 inhibitor. J. Clin. Oncol. 38(5_suppl), 44 (2020).","journal-title":"J. Clin. Oncol."},{"key":"1375_CR10","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck, M., Rodr\u00edguez-Abreu, D., Robinson, A. G., Hui, R., Cs\u0151szi, T., F\u00fcl\u00f6p, A. et al. Pembrolizumab versus chemotherapy for PD-L1\u2013positive non\u2013small-cell lung cancer. N. Engl. J. Med. 375, 1823\u20131833 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1375_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SPC.0000000000000457","volume":"13","author":"D Brocco","year":"2019","unstructured":"Brocco, D., Di Marino, P. & Grassandonia, A. From cachexia to obesity: the role of host metabolism in cancer immunotherapy. Curr. Opin. Support Palliat. Care 13, 305\u2013310 (2019).","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"1375_CR12","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1158\/1078-0432.CCR-18-0415","volume":"24","author":"DC Turner","year":"2018","unstructured":"Turner, D. C., Kondic, A. G., Anderson, K. M., Robinson, A. G., Garon, E. B., Riess, J. W. et al. Pembrolizumab exposure\u2013response assessments challenged by association of cancer cachexia and catabolic clearance. Clin. Cancer Res. 24, 5841\u20135849 (2018).","journal-title":"Clin. Cancer Res."},{"key":"1375_CR13","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/annonc\/mdx345","volume":"28","author":"B Laird","year":"2017","unstructured":"Laird, B. & Fallon, M. Treating cancer cachexia; an evolving landscape. Ann. Oncol. 28, 2055\u20132056 (2017).","journal-title":"Ann. Oncol."},{"key":"1375_CR14","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/annonc\/mdu086","volume":"25","author":"D Blum","year":"2014","unstructured":"Blum, D., Stene, G. B., Solheim, T. S., Fayers, P., Hjermstad, M. J., Baracos, V. E. et al. Validation of the consensus-definition for cancer cachexia and evaluation of a classification model\u2014a study based on data from an international multicentre project (EPCRC-CSA). Ann. Oncol. 25, 1635\u20131642 (2014).","journal-title":"Ann. Oncol."},{"key":"1375_CR15","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1017\/S0007114512004527","volume":"109","author":"BS van der Meij","year":"2013","unstructured":"van der Meij, B. S., Schoonbeek, C. P., Smit, E. F., Muscaritoli, M., van Leeuwen, P. A. & Langius, J. A. Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks. Br. J. Nutr. 109, 2231\u20132239 (2013).","journal-title":"Br. J. Nutr."},{"key":"1375_CR16","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.clnu.2016.09.008","volume":"36","author":"AAL Vigano","year":"2017","unstructured":"Vigano, A. A. L., Morais, J. A., Ciutto, L., Rosenthall, L., di Tomasso, J., Khan, S. et al. Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients. Clin. Nutr. 36, 1378\u20131390 (2017).","journal-title":"Clin. Nutr."},{"key":"1375_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.trecan.2018.10.001","volume":"4","author":"SF Schmidt","year":"2018","unstructured":"Schmidt, S. F., Rohm, M., Herzig, S. & Diaz, M. B. Cancer cachexia: more than skeletal muscle wasting. Trends Cancer 4, 849\u2013860 (2018).","journal-title":"Trends Cancer"},{"key":"1375_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2217\/fon.10.20","volume":"6","author":"MJ Tisdale","year":"2010","unstructured":"Tisdale, M. J. Are tumoral factors responsible for host tissue wasting in cancer cachexia? Future Oncol. 6, 503\u2013513 (2010).","journal-title":"Future Oncol."},{"key":"1375_CR19","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/jbmr.82","volume":"25","author":"MJ Devlin","year":"2010","unstructured":"Devlin, M. J., Cloutier, A. M., Thomas, N. A., Panus, D. A., Lotinun, S., Pinz, I. et al. Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J. Bone Min. Res. 25, 2078\u20132088 (2010).","journal-title":"J. Bone Min. Res."},{"key":"1375_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fphys.2016.00472","volume":"7","author":"R Barreto","year":"2016","unstructured":"Barreto, R., Mandili, G., Witzmann, F. A., Novelli, F., Zimmers, T. A. & Bonetto, A. Cancer and chemotherapy contribute to muscle loss by activating common signaling pathways. Front. Physiol. 7, 472 (2016).","journal-title":"Front. Physiol."},{"key":"1375_CR21","doi-asserted-by":"publisher","first-page":"e13400","DOI":"10.1111\/apha.13400","volume":"229","author":"AE Hiensch","year":"2020","unstructured":"Hiensch, A. E., Bolam, K. A., Mijwel, S., Jeneson, J. A., Huitema, A. D., Kranenburg, O. et al. Doxorubicin\u2010induced skeletal muscle atrophy: elucidating the underlying molecular pathways. Acta Physiol. 229, e13400 (2020).","journal-title":"Acta Physiol."},{"key":"1375_CR22","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.4081\/ejtm.2018.7590","volume":"28","author":"JS Damrauer","year":"2018","unstructured":"Damrauer, J. S., Stadler, M. E., Acharyya, S., Baldwin, A. S., Couch, M. E. & Guttridge, D. C. Chemotherapy-induced muscle wasting: association with NF-\u03baB and cancer cachexia. Eur. J. Transl. Myol. 28, 7590 (2018).","journal-title":"Eur. J. Transl. Myol"},{"key":"1375_CR23","doi-asserted-by":"publisher","first-page":"e106489","DOI":"10.1371\/journal.pone.0106489","volume":"9","author":"TP Braun","year":"2014","unstructured":"Braun, T. P., Szumowski, M., Levasseur, P. R., Grossberg, A. J., Zhu, X., Agarwal, A. et al. Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle. PLoS ONE 9, e106489 (2014).","journal-title":"PLoS ONE"},{"key":"1375_CR24","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.2967\/jnumed.112.115873","volume":"54","author":"A Courtois","year":"2013","unstructured":"Courtois, A., Nusgens, B. V., Hustinx, R., Namur, G., Gomez, P., Somja, J. et al. 18F-FDG uptake assessed by PET\/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. J. Nucl. Med. 54, 1740\u20131747 (2013).","journal-title":"J. Nucl. Med"},{"key":"1375_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF03006668","volume":"17","author":"M Shozushima","year":"2003","unstructured":"Shozushima, M., Tsutsumi, R., Terasaki, K., Sato, S., Nakamura, R. & Sakamaki, K. Augmentation effects of lymphocyte activation by antigen-presenting macrophages on FDG uptake. Ann. Nucl. Med. 17, 555\u2013560 (2003).","journal-title":"Ann. Nucl. Med."},{"key":"1375_CR26","first-page":"1","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts, H. J., Velazquez, E. R., Leijenaar, R. T., Parmar, C., Grossmann, P., Carvalho, S. et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun. 5, 1\u20139 (2014).","journal-title":"Nat. Commun."},{"key":"1375_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19116-x","volume":"11","author":"W Mu","year":"2020","unstructured":"Mu, W., Jiang, L., Zhang, J., Shi, Y., Gray, J. E., Tunali, I. et al. Non-invasive decision support for NSCLC treatment using PET\/CT radiomics. Nat. Commun. 11, 5228 (2020).","journal-title":"Nat. Commun."},{"key":"1375_CR28","doi-asserted-by":"publisher","first-page":"e190063","DOI":"10.1148\/ryai.2019190063","volume":"2","author":"W Mu","year":"2020","unstructured":"Mu, W., Tunali, I., Qi, J., Schabath, M. B. & Gillies, R. J. Radiomics of 18F fluorodeoxyglucose PET\/CT images predicts severe immune-related adverse events in patients with NSCLC. Radio. Artif. Intell. 2, e190063 (2020).","journal-title":"Radio. Artif. Intell."},{"key":"1375_CR29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00259-019-04625-9","volume":"47","author":"W Mu","year":"2020","unstructured":"Mu, W., Tunali, I., Gray, J. E., Qi, J., Schabath, M. B. & Gillies, R. J. Radiomics of 18 F-FDG PET\/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy. Eur. J. Nucl. Med. Mol. Imaging 47, 1168\u20131182 (2020).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1375_CR30","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00259-019-04592-1","volume":"47","author":"J Zhang","year":"2020","unstructured":"Zhang, J., Zhao, X., Zhao, Y., Zhang, J., Zhang, Z., Wang, J. et al. Value of pre-therapy 18 F-FDG PET\/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer. Eur. J. Nucl. Med. Mol. Imaging 47, 1137\u20131146 (2020).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1375_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.acra.2019.04.016","volume":"27","author":"M Jiang","year":"2020","unstructured":"Jiang, M., Sun, D., Guo, Y., Guo, Y., Xiao, J., Wang, L. et al. Assessing PD-L1 expression level by radiomic features from PET\/CT in nonsmall cell lung cancer patients: an initial result. Acad. Radio. 27, 171\u2013179 (2020).","journal-title":"Acad. Radio."},{"key":"1375_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J. et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol. 31, 1539\u20131547 (2013).","journal-title":"J. Clin. Oncol."},{"key":"1375_CR33","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1109\/TBME.2015.2433397","volume":"62","author":"W Mu","year":"2015","unstructured":"Mu, W., Chen, Z., Shen, W., Yang, F., Liang, Y., Dai, R. et al. A segmentation algorithm for quantitative analysis of heterogeneous tumors of the cervix with 18 F-FDG PET\/CT. IEEE Trans. Biomed. Eng. 62, 2465\u20132479 (2015).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"1375_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","volume":"9","author":"N Otsu","year":"1979","unstructured":"Otsu, N. A threshold selection method from gray-level histograms. IEEE Trans. Syst. Man Cyber. Syst. 9, 62\u201366 (1979).","journal-title":"IEEE Trans. Syst. Man Cyber. Syst."},{"key":"1375_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg, A., Valli\u00e8res, M., Abdalah, M. A., Aerts, H. J., Andrearczyk, V., Apte, A. et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiol 295, 328\u2013338 (2020).","journal-title":"Radiol"},{"key":"1375_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1 (2010).","journal-title":"J. Stat. Softw."},{"key":"1375_CR37","doi-asserted-by":"crossref","unstructured":"Lambin, P., Leijenaar, R. T., Deist, T. M., Peerlings, J., De Jong, E. E., Van Timmeren, J. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14, 749\u2013762 (2017).","DOI":"10.1038\/nrclinonc.2017.141"},{"key":"1375_CR38","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"Y-q Huang","year":"2016","unstructured":"Huang, Y.-q, Liang, C.-h, He, L., Tian, J., Liang, C.-s, Chen, X. et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J. Clin. Oncol. 34, 2157\u20132164 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1375_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"E DeLong","year":"1988","unstructured":"DeLong, E., DeLong, D. & Clarke-Pearson, D. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837\u2013845 (1988).","journal-title":"Biometrics"},{"key":"1375_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00330-019-06360-z","volume":"30","author":"JE Park","year":"2020","unstructured":"Park, J. E., Kim, D., Kim, H. S., Park, S. Y., Kim, J. Y., Cho, S. J. et al. Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement. Eur. Radiol. 30, 523\u2013536 (2020).","journal-title":"Eur. Radiol."},{"key":"1375_CR41","doi-asserted-by":"publisher","first-page":"e000097","DOI":"10.1136\/bmjgast-2016-000097","volume":"3","author":"G Vanhoutte","year":"2016","unstructured":"Vanhoutte, G., van de Wiel, M., Wouters, K., Sels, M., Bartolomeeussen, L., De Keersmaecker, S. et al. Cachexia in cancer: what is in the definition? BMJ Open Gastroenterol. 3, e000097 (2016).","journal-title":"BMJ Open Gastroenterol."},{"key":"1375_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12904-019-0429-2","volume":"18","author":"OM Vagnildhaug","year":"2019","unstructured":"Vagnildhaug, O. M., Brunelli, C., Hjermstad, M. J., Strasser, F., Baracos, V., Wilcock, A. et al. A prospective study examining cachexia predictors in patients with incurable cancer. BMC Palliat. Care 18, 1\u201310 (2019).","journal-title":"BMC Palliat. Care"},{"key":"1375_CR43","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3390\/cancers11091251","volume":"11","author":"S Santiloni Cury","year":"2019","unstructured":"Santiloni Cury, S., De Moraes, D., Paccielli Freire, P., De Oliveira, G., Ven\u00e2ncio Pereira Marques, D., Javier Fernandez, G. et al. Tumor transcriptome reveals high expression of IL-8 in non-small cell lung cancer patients with low pectoralis muscle area and reduced survival. Cancers 11, 1251 (2019).","journal-title":"Cancers"},{"key":"1375_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejca.2019.07.023","volume":"120","author":"E de Jong","year":"2019","unstructured":"de Jong, E., Sanders, K., Deist, T., van Elmpt, W., Jochems, A., van Timmeren, J. et al. Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer? Eur. J. Cancer 120, 107\u2013113 (2019).","journal-title":"Eur. J. Cancer"},{"key":"1375_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.stem.2010.05.021","volume":"7","author":"SJ Curtis","year":"2010","unstructured":"Curtis, S. J., Sinkevicius, K. W., Li, D., Lau, A. N., Roach, R. R., Zamponi, R. et al. Primary tumor genotype is an important determinant in identification of lung cancer propagating cells. Cell Stem Cell 7, 127\u2013133 (2010).","journal-title":"Cell Stem Cell"},{"key":"1375_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41591-019-0750-6","volume":"26","author":"AM Laughney","year":"2020","unstructured":"Laughney, A. M., Hu, J., Campbell, N. R., Bakhoum, S. F., Setty, M., Lavall\u00e9e, V. P. et al. Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nat. Med. 26, 259\u2013269 (2020).","journal-title":"Nat. Med."},{"key":"1375_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/hed.20447","volume":"29","author":"M Couch","year":"2007","unstructured":"Couch, M., Lai, V., Cannon, T., Guttridge, D., Zanation, A., George, J. et al. Cancer cachexia syndrome in head and neck cancer patients: Part I. Diagnosis, impact on quality of life and survival, and treatment. Head. Neck 29, 401\u2013411 (2007).","journal-title":"Head. Neck"},{"key":"1375_CR48","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1152\/physiol.00019.2005","volume":"20","author":"MJ Tisdale","year":"2005","unstructured":"Tisdale, M. J. Molecular pathways leading to cancer cachexia. Physiol 20, 340\u2013348 (2005).","journal-title":"Physiol"},{"key":"1375_CR49","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1164\/ajrccm\/137.6.1364","volume":"137","author":"KE Stephens","year":"1988","unstructured":"Stephens, K. E., Ishizaka, A., Larrick, J. W. & Raffin, T. A. Tumor necrosis factor causes increased pulmonary permeability and edema. Am. Rev. Respir. Dis. 137, 1364\u20131370 (1988).","journal-title":"Am. Rev. Respir. Dis."},{"key":"1375_CR50","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2214\/AJR.15.15864","volume":"207","author":"U Bashir","year":"2016","unstructured":"Bashir, U., Siddique, M. M., Mclean, E., Goh, V. & Cook, G. J. Imaging heterogeneity in lung cancer: techniques, applications, and challenges. Am. J. Roentgenol. 207, 534\u2013543 (2016).","journal-title":"Am. J. Roentgenol."},{"key":"1375_CR51","doi-asserted-by":"publisher","first-page":"576314","DOI":"10.3389\/fonc.2020.576314","volume":"10","author":"K Khaddour","year":"2020","unstructured":"Khaddour, K., Gomez-Perez, S. L., Jain, N., Patel, J. D. & Boumber, Y. Obesity, sarcopenia, and outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors. Front. Oncol. 10, 576314 (2020).","journal-title":"Front. Oncol"},{"key":"1375_CR52","doi-asserted-by":"publisher","first-page":"112377","DOI":"10.1016\/j.ejmech.2020.112377","volume":"199","author":"B Cheng","year":"2020","unstructured":"Cheng, B., Ren, Y., Cao, H. & Chen, J. Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1. Eur. J. Med. Chem. 199, 112377 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"1375_CR53","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1002\/cncr.33142","volume":"126","author":"H Borghaei","year":"2020","unstructured":"Borghaei, H., Langer, C. J., Paz-Ares, L., Rodr\u00edguez-Abreu, D., Halmos, B., Garassino, M. C. et al. Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non\u2013small cell lung cancer without tumor PD-L1 expression: a pooled analysis of 3 randomized controlled trials. Cancer 126, 4867\u20134877 (2020).","journal-title":"Cancer"},{"key":"1375_CR54","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.annonc.2020.03.295","volume":"31","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y., Wang, H., Wu, J., Chen, C., Yuan, Q., Huang, W. et al. Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer. Ann. Oncol. 31, 760\u2013768 (2020).","journal-title":"Ann. Oncol."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01375-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01375-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01375-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T11:15:31Z","timestamp":1658315731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01375-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,7,20]]}},"alternative-id":["1375"],"URL":"https:\/\/doi.org\/10.1038\/s41416-021-01375-0","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board at the University of South Florida (USF) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The requirement for informed consent was waived because of the retrospective nature of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The PET\/CT imaging data and clinical information are not publicly available for patient privacy purposes but are available from the corresponding authors upon reasonable request (R.J.G. and M.B.S.). The remaining data are available within the Article and Supplementary Information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"R.J.G. declared a potential conflict with HealthMyne, Inc [Investor, Board of Advisors]. Contents of this research do not represent the views of the Department of Veterans Affairs or the United States Government. The remaining authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was funded by U.S. Public Health Service research grant U01 CA143062 and R01 CA190105 (awarded to R.J.G.).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}